Drugmaker AstraZeneca is harnessing the wisdom of crowds to help mix tomorrow’s cancer drug cocktails.
The company said its decision to release preclinical data from more than 50 of its medicines was unprecedented in scale and would help accelerate the hunt for synergistic tumour-fighting drug combinations.
{iframe}http://www.thestar.com.my/Tech/Tech-News/2015/09/23/AstraZeneca-taps-crowdsourcing-to-find-cancer-drug-cocktails/{/iframe}